HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- methyl- 2,3- diamino- 6- phenyl- dihydrophenanthridine

a radiotracer used to measure reactive oxygen species production; structure in first source

Also Known As:

(3H)hydromethidine; dihydromethidine; hydromethidine

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - Phenanthridines: 3
      - N-methyl-2,3-diamino-6-phenyl-dihydrophenanthridine: 1

Experts

1.	Abe, Kohji: 1 article (12/2015)
2.	Fukumoto, Kazumi: 1 article (12/2015)
3.	Imamoto, Natsumi: 1 article (12/2015)
4.	Inoue, Osamu: 1 article (12/2015)
5.	Ito, Miwa: 1 article (12/2015)
6.	Momosaki, Sotaro: 1 article (12/2015)
7.	Morimoto, Kenji: 1 article (12/2015)
8.	Rokugawa, Takemi: 1 article (12/2015)
9.	Takai, Nozomi: 1 article (12/2015)
10.	Tonomura, Misato: 1 article (12/2015)

Related Diseases

1.	Ischemia 12/01/2015 - "In this study, we investigate the generation of brain ROS after transient focal ischemia in mice using a radical trapping radiotracer, [(3)H]-labeled N-methyl-2,3-diamino-6-phenyl-dihydrophenanthridine ([(3)H]hydromethidine), which we recently reported as a ROS imaging probe. "
2.	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/01/2015 - "[(3)H]Hydromethidine was intravenously injected into mice at 1, 2, 5, and 7 h after transient middle cerebral artery occlusion (tMCAO), and then, the brain autoradiogram was acquired at 60 min after tracer injection. "

Related Drugs and Biologics

1.	N- methyl- 2,3- diamino- 6- phenyl- dihydrophenanthridine